Xingshu Li Selected Research

copper phthalocyanine (phthalocyanine blue)

2/2018

New application of phthalocyanine molecules: from photodynamic therapy to photothermal therapy by means of structural regulation rather than formation of aggregates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xingshu Li Research Topics

Disease

35	Neoplasms (Cancer) 06/2022 - 05/2015
25	Alzheimer Disease (Alzheimer's Disease) 02/2019 - 12/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2019
2	Phototoxic Dermatitis (Phototoxicity) 06/2022 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2021
2	Hypoxia (Hypoxemia) 01/2021 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 10/2018 - 02/2018
1	Fibrosis (Cirrhosis) 05/2022
1	Bacterial Infections (Bacterial Infection) 02/2022
1	Esophageal Neoplasms (Esophageal Cancer) 05/2021
1	Skin Neoplasms (Skin Cancer) 05/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2021
1	Adenocarcinoma of Lung 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Colonic Neoplasms (Colon Cancer) 12/2018
1	Liver Neoplasms (Liver Cancer) 10/2018
1	Esophageal Squamous Cell Carcinoma 09/2018
1	Carcinoma (Carcinomatosis) 09/2018
1	Photosensitivity Disorders (Photodermatitis) 02/2018

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 02/2022 - 12/2011
10	LigandsIBA 02/2019 - 10/2012
9	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 01/2017
6	Biological ProductsIBA 01/2022 - 02/2014
6	Photosensitizing Agents (Photosensitizers)IBA 05/2021 - 01/2017
6	Tacrine (Cognex)FDA Link 01/2019 - 05/2012
5	TubulinIBA 01/2022 - 01/2017
5	AntioxidantsIBA 11/2018 - 10/2012
5	ebselenIBA 11/2018 - 11/2013
4	AlbuminsIBA 06/2022 - 01/2019
4	Clioquinol (Vioform)FDA Link 02/2019 - 08/2014
4	ResveratrolIBA 05/2015 - 12/2012
3	indoleIBA 01/2022 - 01/2017
3	quinolineIBA 10/2019 - 01/2018
3	Trace Elements (Biometals)IBA 02/2019 - 07/2015
3	Cholinesterases (Cholinesterase)IBA 01/2019 - 04/2013
3	Tubulin ModulatorsIBA 01/2018 - 01/2016
3	Monoamine Oxidase (MAO)IBA 07/2015 - 10/2012
2	NitrogenIBA 05/2022 - 10/2018
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 02/2021
2	biotin receptorIBA 10/2019 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019 - 10/2018
2	RoflumilastIBA 02/2019 - 03/2013
2	AcetylcholinesteraseIBA 01/2019 - 12/2015
2	Glutathione PeroxidaseIBA 11/2018 - 02/2014
2	Oxygen (Dioxygen)IBA 02/2018 - 01/2018
2	Therapeutic UsesIBA 06/2017 - 01/2017
2	Phosphates (Orthophosphate)IBA 01/2017 - 01/2016
2	Donepezil (Aricept)FDA LinkGeneric 01/2017 - 11/2013
2	SaltsIBA 01/2017 - 01/2016
2	Chelating AgentsIBA 02/2016 - 07/2015
2	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 01/2016 - 07/2015
2	MetalsIBA 07/2015 - 10/2012
2	Selegiline (E250)FDA LinkGeneric 07/2015 - 04/2013
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 02/2014 - 11/2013
2	BerberineIBA 05/2012 - 12/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022
1	pirfenidoneIBA 05/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	(1,2- bis(1,2- benzisoselenazolone- 3(2H)- ketone))ethaneIBA 01/2022
1	ThioredoxinsIBA 01/2022
1	Chalcone (Benzalacetophenone)IBA 01/2022
1	Pemetrexed (MTA)FDA Link 01/2022
1	AcidsIBA 01/2022
1	PyrimidinesIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 02/2021
1	brigatinibIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 01/2021
1	ProdrugsIBA 01/2021
1	ceritinibIBA 01/2021
1	AQ4NIBA 01/2021
1	phthalocyanineIBA 01/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 12/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2019
1	fluorexon (calcein)IBA 10/2019
1	RolipramIBA 02/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019
1	benzocycloheptapyridineIBA 01/2019
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Coloring Agents (Dyes)IBA 12/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2018
1	Histone Deacetylase InhibitorsIBA 11/2018
1	BoronIBA 11/2018
1	3- (4,5- dimethylthiazol- 2- yl)- 5- (3- carboxymethoxyphenyl)- 2- (4- sulfophenyl)- 2H- tetrazoliumIBA 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 10/2018
1	Insulin-Like PeptidesIBA 09/2018
1	Cisplatin (Platino)FDA LinkGeneric 09/2018
1	copper phthalocyanine (phthalocyanine blue)IBA 02/2018
1	2,6-dimethyl-4-aminopyrimidineIBA 01/2018

Therapy/Procedure

17	Therapeutics 01/2022 - 01/2016
10	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2017
4	Drug Therapy (Chemotherapy) 01/2022 - 10/2019
4	Photothermal Therapy 05/2021 - 02/2018
3	Immunotherapy 01/2022 - 01/2021
2	Phototherapy (Light Therapy) 06/2022 - 11/2020
2	Intravenous Injections 01/2021 - 01/2021
2	Lasers (Laser) 01/2019 - 01/2017
2	Oral Administration 01/2018 - 11/2015